Tregs are recruited through the binding of CCR4 on Tregs surface and CCL22 released by GBM tumor cells and CD163+ TAMs, induced by tumor-derived CCL20 and osteoprotegerin [168,169]. The gene discussed is CCL22; the disease is neoplasm.